Full Text View
Tabular View
No Study Results Posted
Related Studies
Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders
This study has been completed.
Study NCT00551200   Information provided by Hyperion Therapeutics, Inc.

First Received on October 26, 2007.   Last Updated on July 14, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Urea Cycle Disorders
Additional conditions recognized in this trial
Urea Cycle Disorders, Inborn
More general conditions related to this trial
Amino Acid Metabolism, Inborn Errors
Brain Diseases
Brain Diseases, Metabolic
Brain Diseases, Metabolic, Inborn
Central Nervous System Diseases
Genetic Diseases, Inborn
Metabolic Diseases
Metabolism, Inborn Errors
Nervous System Diseases
Interventions listed in this trial
HPN-100
Additional drug interventions recognized in this trial
4-phenylbutyric acid
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Hyperion Therapeutics, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services